Page last updated: 2024-09-05

sorafenib and Hypercalcemia

sorafenib has been researched along with Hypercalcemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Araki, A; Asayama, I; Kanasaki, K; Makino, H; Miyake, H; Morita, M; Nakao, M; Notsu, M; Otani, H; Uchino, S; Yamamoto, M; Yamauchi, M1

Other Studies

1 other study(ies) available for sorafenib and Hypercalcemia

ArticleYear
Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma.
    Internal medicine (Tokyo, Japan), 2022, Nov-15, Volume: 61, Issue:22

    Topics: Denosumab; Humans; Hypercalcemia; Male; Middle Aged; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Sorafenib

2022